Drug Discovery World
APRIL 18, 2024
Gepotidacin is an investigational bactericidal, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by a novel mechanism of action and binding site and for most pathogens provides well-balanced inhibition of two different Type II topoisomerase enzymes. success rate.
Agency IQ
OCTOBER 12, 2023
While this development, on its own, is noteworthy, the judiciary rationale behind the ruling will impact wider EU trends and serve as precedent for future chemical regulation. This regulation has since been repealed and replaced with Implementing Regulation (EU) 2020/1740 , though many of the provisions and their articles remain the same.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Agency IQ
AUGUST 11, 2023
Given this significance, it’s worth analyzing its chaotic regulatory history, examining the implications of the risk assessment document itself, and projecting how this controversial active substance is likely to be treated by EU regulators going forward. The EU adopted an amendment allowing for this on the same day the AGG was formed.
New Drug Approvals
JANUARY 9, 2024
Nature Cell Biology, 11, 1275 – 1276, 2009), whilst different tumors appear to require some, but they are independent of other interphase CDKs (CDK2, CDK4 , CDK6). CDK7 also plays a role in transcription and possibly in DNA repair. In addition to CDK7, other CDKs have been reported to phosphorylate and regulate RNA pol (II) CTD.
Drug Discovery World
JULY 15, 2022
The remaining 8% of the genome was often referred to as the dark matter of the genome or sometimes even ‘Junk DNA’ 2. The sequencing technology relied on could only yield sequences of relatively short DNA fragments, so the assembly of sequences from highly repetitive regions was a huge challenge.
PLOS: DNA Science
SEPTEMBER 21, 2023
Biochemist Richard Lumb founded Front Line Genomics in 2009, when he lost his father to mesothelioma, a rare cancer associated with asbestos exposure. What steps should researchers take when attempting to acquire DNA samples from modern descendants? An ethics session will cover polygenic risk scores and pharmacogenomics.
PLOS: DNA Science
APRIL 4, 2024
The earliest patent I found was issued in late 2009, for “Products and Methods for Reducing Malodor from the Pudendum.” Fishy Regulations Lume falls under the cosmetic category at FDA and so needn’t have undergone clinical trials, because it doesn’t treat an illness or condition. ” Lady parts.
Expert insights. Personalized for you.
130 
Let's personalize your content